Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 28, 2019
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2018.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes or comparative financial data are disclosed within the text of this Form 8-K. The document serves solely to notify the SEC of the issuance of a press release regarding the 2018 results.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 4:30 PM EST on February 28, 2019, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for Q4 and FY 2018.
- Verify the details of the conference call held on February 28, 2019, for management's outlook and guidance.
- Confirm whether the press release contains any forward-looking statements or risk factors not detailed in this 8-K cover sheet.